ASP Isotopes Plans Johannesburg Stock Exchange Listing, Sets New Milestones in Isotope Enrichment Operations

ASP Isotopes plans to list on the Johannesburg Stock Exchange, with commercial production of Silicon-28 and Ytterbium-176 underway. The company is expanding its capabilities and plans to spin out its Quantum Leap Enrichment subsidiary and acquire Renergen in 2025. Despite delays and regulatory inspections, ASP Isotopes is poised to enhance its production capacity and meet growing demand.

ASP Isotopes Inc. is poised to expand its presence in the South African market by listing its common stock on the Johannesburg Stock Exchange (JSE). The company, known for its proprietary Aerodynamic Separation Process (ASP) technology, is currently engaged in commercial production of Silicon-28 and Ytterbium-176, with plans to spin out its Quantum Leap Enrichment subsidiary and acquire Renergen in 2025.

ASP Isotopes is expected to commence trading on the JSE on Wednesday, August 27, 2025, following a secondary listing event scheduled for South African investors on Tuesday, August 26, 2025. The secondary listing is not connected to any current capital raising efforts, and the company will retain its primary listing on the Nasdaq Capital Market.

The company's management team, including Paul Mann, Chairman and CEO, will feature on a RedChip Investor call on Thursday, August 28, 2025, at 4:15 pm EDT. Joining Mann will be Ryno Pretorius, CEO of Quantum Leap Energy, and Stefano Marani, CEO of Renergen. This call will provide investors with an opportunity to ask questions and gain insights into the company's operations and future plans.

ASP Isotopes has made significant progress in its isotope enrichment facilities in Pretoria, South Africa. The company shipped its first samples of enriched Silicon-28 to a US-based customer during August 2025 and expects to complete the enrichment of the first samples of Ytterbium 176 during the same month. The company is also working on enriching Carbon-12 to 99.99% for a US customer, with the first commercial product expected to be supplied in September 2025.

Despite facing delays in the construction of equipment for semi-continuous processing and regulatory inspections, ASP Isotopes remains committed to enhancing its production capacity. The company is currently operating its Ytterbium-176 enrichment plant in a batch processing mode but expects to transition to a semi-continuous processing method towards the end of 3Q or the beginning of 4Q 2025. This transition will allow for the production of larger quantities of enriched product.

ASP Isotopes is also exploring the possibility of expanding the capacity of its Carbon enrichment facility to supply both Carbon-12 and Carbon-14. The company believes that its Aerodynamic Separation Process represents a superior method of separation with a significant reduction in capital costs and comparable operating costs.

In addition to its plans for expansion, ASP Isotopes is also focused on the development of Quantum Enrichment technology for the nuclear energy sector. The company is accelerating plans to construct enrichment facilities in South Africa for additional isotopes using the QE process.

Overall, ASP Isotopes is well-positioned to meet growing demand for isotopes in various industries, including healthcare, technology, and green energy. The company's commitment to innovation and expansion, coupled with its experienced management team, makes it an attractive investment opportunity for those seeking exposure to the isotope market.

References:
[1] https://www.marketscreener.com/news/asp-isotopes-inc-hosts-south-african-investors-in-advance-of-secondary-listing-on-the-johannesburg-ce7c50d9db89f421